Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fluoxetine for COVID-19 outcomes
NCT04377308Phase 4Completed
- Sponsor
- University of Toledo Health Science Campus
- Start
- May 2020
- Primary completion
- Apr 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of fluoxetine in coronavirus disease 2019 (COVID-19), sponsored by University of Toledo Health Science Campus. Started May 2020; status: completed.
02
Drugs
fluoxetine
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04377308.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04377308.